XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.24.3

Goodwill and Intangible Assets | 9 Months Ended
--- | ---
Sep. 30, 2024
Goodwill and Intangible Assets |
Goodwill and Intangible Assets | Note 10. Goodwill and Intangible Assets ​ The table below shows the weighted-average life, original cost, accumulated amortization, and net book value by major intangible asset classification: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Weighted-Average | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​ |
​ |  | Life (Years) |  | Original Cost |  | Amortization |  | Net Book Value |
​ | ​ | (in thousands) |
Definite-lived intangible assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
BAQSIMI® product rights(1) | ​ | 24 | ​ | $ | 591,338 | ​ | $ | 30,799 | ​ | $ | 560,539 | ​
Patents |  | 15 | ​ |  | 193 | ​ | ​ | 92 | ​ |  | 101 | ​
Land-use rights |  | 39 | ​ |  | 2,540 | ​ | ​ | 865 | ​ |  | 1,675 | ​
Subtotal |  | 24 | ​ |  | 594,071 | ​ |  | 31,756 | ​ |  | 562,315 | ​
Indefinite-lived intangible assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trademark |  | * | ​ |  | 29,225 | ​ |  | — | ​ |  | 29,225 | ​
Goodwill - Finished pharmaceutical products |  | * | ​ |  | 3,256 | ​ |  | — | ​ |  | 3,256 | ​
Subtotal |  | * | ​ |  | 32,481 | ​ |  | — | ​ |  | 32,481 | ​
As of September 30, 2024 |  | * | ​ | $ | 626,552 | ​ | $ | 31,756 | ​ | $ | 594,796 | ​
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Weighted-Average | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​ |
​ |  | Life (Years) |  | Original Cost |  | Amortization |  | Net Book Value |
​ | ​ | (in thousands) |
Definite-lived intangible assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
BAQSIMI® product rights(1) | ​ | 24 | ​ | $ | 591,338 | ​ | $ | 12,319 | ​ | $ | 579,019 | ​
Patents |  | 12 | ​ |  | 486 | ​ | ​ | 376 | ​ |  | 110 | ​
Land-use rights |  | 39 | ​ |  | 2,540 | ​ | ​ | 815 | ​ |  | 1,725 | ​
Subtotal |  | 24 | ​ |  | 594,364 | ​ |  | 13,510 | ​ |  | 580,854 | ​
Indefinite-lived intangible assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trademark |  | * | ​ |  | 29,225 | ​ |  | — | ​ |  | 29,225 | ​
Goodwill - Finished pharmaceutical products |  | * | ​ |  | 3,216 | ​ |  | — | ​ |  | 3,216 | ​
Subtotal |  | * | ​ |  | 32,441 | ​ |  | — | ​ |  | 32,441 | ​
As of December 31, 2023 |  | * | ​ | $ | 626,805 | ​ | $ | 13,510 | ​ | $ | 613,295 | ​
* Intangible assets with indefinite lives have an indeterminable average life.
(1) | See Note 3.
​ Goodwill ​ The changes in the carrying amounts of goodwill are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31, |
​ | ​ | 2024 | ​ | 2023 |
​ | ​ | (in thousands) |
Beginning balance |  | $ | 3,216 |  | $ | 3,126 | ​
Currency translation | ​ |  | 40 | ​ |  | 90 | ​
Ending balance | ​ | $ | 3,256 | ​ | $ | 3,216 | ​
​

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration